• About
  • Masthead
  • License Content
  • Advertise
  • Submit Press Release
  • RSS/Email List
  • 2MM Podcast
  • Write for us
  • Contact Us
2 Minute Medicine
No Result
View All Result

No products in the cart.

SUBSCRIBE
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
2 Minute Medicine
  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools+
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan+
  • Classics™+
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
SUBSCRIBE
2 Minute Medicine
Subscribe
EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine
Home All Specialties Chronic Disease

Alternate-day fasting not superior than calorie restriction in adults

byAnees DaudandJames England
May 4, 2017
in Chronic Disease, Endocrinology, Public Health
Reading Time: 3 mins read
Parent/child feeding practices associated with weight status
Share on FacebookShare on Twitter

1. Based on this randomized clinical trial, alternate-day fasting did not yield different results with regards to weight loss, blood pressure, or lipid profiles compared to a typical, caloric-restriction strategy.

2. The alternate-day fasting strategy had significantly worse compliance compared to calorie restriction or control.

Evidence Rating Level: 2 (Good)       

Study Rundown: Obesity remains one of the top public health issues in the developed world. Efforts for weight loss often involve increased physical activity and caloric restriction. Due to poor compliance with typical restriction strategies, an alternate-day fasting model has emerged. The current study sought to compare an alternate-day fasting approach to traditional calorie restriction and no intervention to investigate for any specific weight loss and metabolic benefits. Weight loss was not different between the two intervention groups, but was more than in the control group. Blood pressure, heart rate, insulin, C-reactive protein, triglyceride, and HDL levels did not differ in long-term follow up between the two intervention groups. The alternate-day fasting group had worse adherence and a greater dropout rate than with the traditional restriction or control groups.

The strengths of the study included randomized control design, controlling for known covariates, and long length of follow-up. Weaknesses of the study included the high rate of dropout, particularly in the alternate-day fasting group. While the drop-out rate may reflect a real-world scenario, it does hinder the ability of the study to determine the effectiveness of the alternate-day fasting model. The study population was also predominantly female and black, and may not be generalizable to other populations.

Click to read the study, published in JAMA Internal Medicine

RELATED REPORTS

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

The Scan by 2 Minute Medicine®: popular joint supplement raises Alzheimer’s red flags, the gut health industry is outrunning the science, chronic wasting disease is spreading silently and scientists are watching closely, and the oral GLP-1 pill era begins with Foundayo

Relevant Reading: The effects of modified alternate-day fasting diet on weight loss and CAD risk factors in overweight and obese women

In-Depth [randomized controlled trial]: This study enrolled patients from 2011 to 2015 at a single institution at the University of Illinois. Adults 18 to 65 years of age were included if they had a body mass index between 25.0 and 39.9 and were sedentary (<60 minutes of light activity/week). Participants were excluded if they had established cardiovascular disease, diabetes, medications that could affect study outcomes, unstable weight, pregnancy, perimenopause, or were active smokers. Randomization occurred in a 1:1:1 ratio, with a 1-month baseline phase. The weight loss phase consisted of alternating 25% and 125% of per day of baseline energy intake for the alternate-day fasting group, and 75% of baseline energy intake for the typical restriction group. The maintenance phase consisted of alternating 50% and 150% of baseline energy/day for the alternate-day fasting group, and 100% of baseline intake for the restriction group. The control group received no specific counselling or instructions beyond attempting to maintain baseline weight.

The study group included 100 participants with a mean age of 44 years, 86% were female, and 63% were black. The alternate-day fasting group had weight loss of -6.0% (95%CI -8.5% to -3.6%), similar to -5.3% (95%CI -7.6% to -3.0%) in the calorie restriction group. There was no significant difference in weight re-gain. There was no observed difference in blood pressure, heart rate, fasting glucose, serum insulin, or triglycerides between the intervention groups, but LDL was higher in the alternative fasting group (11.5 mg/dL; 95%CI 1.9-21.1 mg/dL). The dropout rate for the fasting group was 38% vs. 29% in the restriction group and 26% in the control group.

Image: PD

©2017 2 Minute Medicine, Inc. All rights reserved. No works may be reproduced without expressed written consent from 2 Minute Medicine, Inc. Inquire about licensing here. No article should be construed as medical advice and is not intended as such by the authors or by 2 Minute Medicine, Inc.

Tags: dietobesityweight loss
Previous Post

Behavioral intervention improved antibiotic prescribing appropriateness

Next Post

High risk of complications, but low mortality among children with MRSA bacteremia

RelatedReports

Increasing maternal BMI linked to higher risk of cerebral palsy
Endocrinology

Newer GLP-1 agents yield substantial weight loss in nondiabetic adults

August 31, 2026
Fatty liver disease may independently predict high-risk coronary disease
Cardiology

Weight loss is associated with improved vascular function in patients with metabolic dysfunction-associated steatotic liver disease

August 21, 2026
The Scan by 2 Minute Medicine®:  Ultra-Trail du Mont-Blanc, Taylor Swift, NBA rookie Chet Holmgren and Magic Mushrooms!
Chronic Disease

The Scan by 2 Minute Medicine®: popular joint supplement raises Alzheimer’s red flags, the gut health industry is outrunning the science, chronic wasting disease is spreading silently and scientists are watching closely, and the oral GLP-1 pill era begins with Foundayo

July 9, 2026
Weekly Rewinds

2 Minute Medicine Rewind June 29, 2026

June 29, 2026
Next Post
High risk of complications, but low mortality among children with MRSA bacteremia

High risk of complications, but low mortality among children with MRSA bacteremia

Interstitial lung abnormalities linked to greater risk of all-cause mortality

Novel imaging agent could enable pulmonary fibrosis diagnosis and monitoring [PreClinical]

Pharmaceutical industry sponsored meals linked to increased prescribing of promoted medications

Current trends in financial relationships between industry and physicians

EvidencePulse™ by 2 Minute Medicine 2026 evidence scan 3 reports You asked top stroke trials 2026 Synthesizing medical evidence... Top 2026 stroke trial results: OCEANIC — ischemic stroke: 6.2% vs 8.4% OPTION* — mRS 0–1: 43.6% vs 34.2% ORIENTAL* — mRS 0–2: 58.6% vs 46.6% *Higher sICH in intervention arms Participants randomizedN OCEANIC 12,327 OPTION 570 ORIENTAL 564 Ask about guidelines or landmark trials... ↑ Try EvidencePulse™ Ask the evidence.
Get the signal.
Try it now → Physician-trained medical AI by 2 Minute Medicine

2MM+ All Access

Full details →
$4.99 /month

5-day free trial · cancel anytime

  • ✓100+ physician-written reports
  • ✓EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters
Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

  • Increased rapid eye movement (REM) sleep is associated with lower risks of several chronic diseases
  • The use of neoadjuvant chemotherapy in patients with advanced epithelial ovarian cancer may reduce mortality
  • Alcohol use declines but remains above pre-pandemic levels
License Content
Terms of Use | Disclaimer
Cookie Policy
Cleantalk Pixel
2MM+ All Access Full details →

The medical literature, distilled daily.

Monthly plan selected: $4.99 /month.

$4.99/month

5-day free trial · cancel anytime

Start 5-day free trial

Then $4.99/month. Manage renewal in your account.

Yearly plan selected: $49.90 /year.

$49.90/year

2 months free · only $4.16/month

Start 5-day free trial

Then $49.90/year. Manage renewal in your account.

Membership benefits

  • ✓100+ physician-written reports
  • ✓AI EvidencePulse™ + HypeCheck™
  • ✓Ad-free reading + newsletters

Already a member? Sign in

  • About
  • Specialties
    • All Specialties, All Recent Reports
    • Cardiology
    • Chronic Disease
    • Dermatology
    • Emergency
    • Endocrinology
    • Gastroenterology
    • Imaging and Intervention
    • Infectious Disease
    • Nephrology
    • Neurology
    • Obstetrics
    • Oncology
    • Ophthalmology
    • Pediatrics
    • Pharma
    • Preclinical
    • Psychiatry
    • Public Health
    • Pulmonology
    • Rheumatology
    • Surgery
  • Tools
    • EvidencePulse™
    • HypeCheck™
    • NPI Registry Lookup
    • RVU Search
  • Pharma
  • AI Roundup
  • The Scan
  • Classics™
    • 2MM+ Online Access
    • Paperback and Ebook
  • Rewinds
  • Partners
    • License Content
    • Submit Press Release
    • Advertise with Us
  • Account
    • Subscribe
    • My account
    • Cart
    • Sign-in
No Result
View All Result

© 2026 2 Minute Medicine, Inc. - Physician-written medical news.